# BCLAF1 regulates expression of AP-1 genes and hematopoietic stem cell repopulating activity

> **NIH NIH F31** · WASHINGTON UNIVERSITY · 2024 · $34,623

## Abstract

PROJECT SUMMARY
Hematopoietic stem cells (HSC) maintain both a self-renewal capacity to persist throughout life and an ability to
differentiate to downstream progenitors to generate blood cell lineages. Stem cells balance these fates through
symmetric and asymmetric divisions, respectively. HSC self-renewal and symmetric division are necessary for
rapid expansion of HSCs in fetal development as well as repopulation of bone marrow following stem cell
transplantation. Recently, the transcriptional regulator Bclaf1 (Bcl2 associated transcription factor 1) was shown
to support both fetal and adult HSC function. Bclaf1 is ubiquitously expressed in hematopoietic cells but its
function in normal hematopoiesis has not been elucidated. We recently characterized BCLAF1 as a modulator
of ETS-family transcription factor activity in developing B cells. Bclaf1 is highly expressed in HSCs, which also
rely on ETS-family transcription factors for development and function, consistent with a potential role for BCLAF1
in HSC activities. To test whether BCLAF1 regulates HSC development and hematopoiesis, we used murine
models with germline loss of function and with selective deletion of BCLAF1 in hematopoietic cells. We find that
Vav-cre:Bclaf1fl/fl mice have significantly reduced numbers of HSCs at embryonic day 17.5 (E17.5) that persists
into adulthood, but does not exaggerate over time. To further characterize the function of BCLAF1 in HSCs in
adult mice, we treated 8-week old Mx-cre:Bclaf1fl/fl mice with polyinosinic:polycytidylic acid (pIpC) to delete Bclaf1
in established adult HSCs. Loss of BCLAF1 did not alter HSC numbers in the adult bone marrow as compared
to pIpC-treated Bclaf1fl/fl control mice. These findings demonstrate that BCLAF1 supports HSC development
beginning in fetal populations but is not required for homeostasis of adult bone marrow HSCs. We performed
competitive reconstitution assays with limited numbers of HSCs to investigate if BCLAF1 is required for HSC
repopulation function. HSCs were sorted from fetal livers of BCLAF1-sufficient or -deficient mice and
transplanted along with wild-type competitor bone marrow cells into lethally-irradiated recipient mice. Mice
transplanted with Vav-cre:Bclaf1fl/fl HSCs had significantly reduced hematopoietic repopulation with lower
percentage of donor-derived leukocytes and reduced percentage of donor HSCs at 16 weeks post-transplant
than mice with Bclaf1fl/fl donor HSCs. This phenotype is consistent between fetal and adult donor HSCs from
Vav-Cre:Bclaf1fl/fl mice. Additionally, single cell CITEseq reveals that BCLAF1-deficient HSCs have significantly
upregulated AP-1 factors JUN and FOS. Collectively, our findings reveal that BCLAF1 is a novel regulator of
fetal HSC development and HSC repopulation activity. On-going studies are investigating the mechanism of
BCLAF1 function in HSCs and the activity of BCLAF1 as a transcription factor to regulate AP-1.

## Key facts

- **NIH application ID:** 10823918
- **Project number:** 1F31HL165908-01A1
- **Recipient organization:** WASHINGTON UNIVERSITY
- **Principal Investigator:** Stephanie Crowley
- **Activity code:** F31 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $34,623
- **Award type:** 1
- **Project period:** 2024-01-01 → 2025-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10823918

## Citation

> US National Institutes of Health, RePORTER application 10823918, BCLAF1 regulates expression of AP-1 genes and hematopoietic stem cell repopulating activity (1F31HL165908-01A1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10823918. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*